Literature DB >> 8018327

Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survival.

G L Clayman1, M G Stewart, R S Weber, A K el-Naggar, E A Grimm.   

Abstract

OBJECTIVE: To determine the relationship between human papillomavirus (HPV) DNA detection in upper aerodigestive tract malignancies and patient outcome.
DESIGN: Archival paraffin-embedded specimens from 78 previously untreated patients with squamous carcinomas of the larynx and hypopharynx were pathologically verified and analyzed by polymerase chain reaction for detection of HPV DNA. Charts were independently reviewed and coded until final analysis.
SETTING: The University of Texas M. D. Anderson Cancer Center, Houston, a tertiary cancer referral center.
RESULTS: DNA was successfully extracted from 65 archival patient samples (83%). The mean (+/- SEM) duration of follow-up for these patients was 42 +/- 21 months. Thirty specimens (46%) exhibited detectable HPV DNA. Detection of HPV was significantly related to decreased survival, independent of disease stage. Log rank testing revealed that HPV detection, pathologic vascular invasion, and nodal status were the most significant predictors of death of disease.
CONCLUSIONS: Laryngeal and hypopharyngeal carcinomas with detectable HPV may represent a biologically distinct subset of tumors that carry a poorer prognosis than do cancers with no detectable HPV.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8018327     DOI: 10.1001/archotol.1994.01880310047009

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  16 in total

Review 1.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

2.  Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.

Authors:  Huaising C Ko; Paul M Harari; Ryan M Sacotte; Shuai Chen; Aaron M Wieland; Menggang Yu; Andrew M Baschnagel; Justine Y Bruce; Randall J Kimple; Matthew E Witek
Journal:  J Cancer Res Clin Oncol       Date:  2017-07-27       Impact factor: 4.553

Review 3.  Oral Sex and HPV: Population Based Indications.

Authors:  Anupam Mishra; Veerendra Verma
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-02-29

4.  High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated with poor clinical outcome of laryngeal carcinoma.

Authors:  G Szládek; A Juhász; G Kardos; K Szoke; T Major; I Sziklai; I Tar; I Márton; J Kónya; L Gergely; K Szarka
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

Review 5.  The role of human papillomavirus in squamous carcinoma of the head and neck.

Authors:  Guojun Li; Erich M Sturgis
Journal:  Curr Oncol Rep       Date:  2006-03       Impact factor: 5.075

6.  Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base.

Authors:  Sibo Tian; Jeffrey M Switchenko; Jaymin Jhaveri; Richard J Cassidy; Matthew J Ferris; Robert H Press; Neil T Pfister; Mihir R Patel; Nabil F Saba; Mark W McDonald; Kristin A Higgins; David S Yu; Walter J Curran; Theresa W Gillespie; Jonathan J Beitler
Journal:  Cancer       Date:  2019-04-23       Impact factor: 6.860

7.  The characteristics of human papillomavirus DNA in head and neck cancers and papillomas.

Authors:  T Major; K Szarka; I Sziklai; L Gergely; J Czeglédy
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

8.  The presence and prognostic significance of human papillomavirus in squamous cell carcinoma of the larynx.

Authors:  Evren Erkul; Ismail Yilmaz; Gizem Narli; Mustafa Alparslan Babayigit; Atila Gungor; Dilaver Demirel
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-04-21       Impact factor: 2.503

9.  Recent advances in managing human papillomavirus-positive oropharyngeal tumors.

Authors:  Giulio Cantu; Stefano Riccio; Sarah Colombo; Madia Pompilio; Paolo Formillo
Journal:  F1000 Med Rep       Date:  2010-03-15

10.  Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx.

Authors:  Xiaoxiang Guan; Erich M Sturgis; Xicheng Song; Zhensheng Liu; Adel K El-Naggar; Qingyi Wei; Guojun Li
Journal:  Cancer Lett       Date:  2012-12-05       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.